Skip to main content
. 2017 Jun 6;38(1):3–20. doi: 10.3892/or.2017.5701

Table V.

Differentially expressed miRNAs in MNA vs. MNnA NB tumours.

miRNA log2FC FDR Status Refs. MYCN-binding motif
miR-517b-3p   7.40 0.01263 Upregulated Novel in NB 0
miR-183-5p   4.07 0.01311 Upregulated (52) 0
miR-182-5p   3.93 0.01263 Upregulated (53) 0
miR-451a   3.45 0.01851 Upregulated (61) 0
miR-217   3.29 0.00962 Upregulated Novel in NB 0
miR-18b-5p   3.18 0.01137 Upregulated (18) 2
miR-3182   2.85 0.02742 Upregulated Novel in NB 0
miR-105-5p   2.84 0.03751 Upregulated (62) 0
miR-20a-5p   2.80 0.01263 Upregulated (18,48,62,63,74) 1
miR-130b-3p   2.79 0.01263 Upregulated (61) 0
miR-935   2.69 0.02807 Upregulated (62) 0
miR-18a-5p   2.64 0.01263 Upregulated (56,62,63,74) 1
miR-130b-5p   2.64 0.01440 Upregulated Novel in NB 0
miR-17-5p   2.57 0.01851 Upregulated (18,48,55,62) 1
miR-301b-3p   2.44 0.03073 Upregulated Novel in NB 0
miR-16-2-3p   2.38 0.01263 Upregulated Novel in NB 0
miR-92a-3p   2.12 0.04003 Upregulated (18,55,62,63,76) 1
miR-489-3p −3.25 0.01263 Downregulated Novel in NB 2
miR-628-5p −2.53 0.01137 Downregulated (62,63) 0
miR-338-5p −2.40 0.01263 Downregulated Novel in NB 1
miR-491-5p −2.23 0.01263 Downregulated (76) 0
miR-628-3p −2.16 0.01851 Downregulated (18,48,62,63) 1
miR-3065-3p −2.10 0.03073 Downregulated Novel in NB 1

FDR, false discovery rate; FC, fold-change; NB, neuroblastoma.